Ingevity Corp
$ 77.82
0.62%
07 Aug - close price
- Market Cap 1,511,470,000 USD
- Current Price $ 77.82
- High / Low $ 78.07 / 76.77
- Stock P/E N/A
- Book Value 6.44
- EPS -9.75
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.08 %
- ROE -0.88 %
- 52 Week High 51.67
- 52 Week Low 28.49
About
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, Asia-Pacific, Europe, the Middle East, Africa, and South America. The company is headquartered in North Charleston, South Carolina.
Analyst Target Price
$51.75
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-07-29 | 2026-05-06 | 2026-02-25 | 2025-11-05 | 2025-08-04 | 2025-05-05 | 2025-02-18 | 2024-10-29 | 2024-07-31 | 2024-05-01 | 2024-02-21 | 2023-11-01 |
| Reported EPS | 1.74 | 1.15 | 0.63 | 1.31 | 1.39 | 0.99 | 0.95 | 1.1 | 1.01 | 0.52 | 0.21 | 1.21 |
| Estimated EPS | 1.31 | 0.83 | 0.6869 | 1.35 | 1.16 | 0.74 | 0.3075 | 0.9 | 1.04 | 0.25 | -0.19 | 1.23 |
| Surprise | 0.43 | 0.32 | -0.0569 | -0.04 | 0.23 | 0.25 | 0.6425 | 0.2 | -0.03 | 0.27 | 0.4 | -0.02 |
| Surprise Percentage | 32.8244% | 38.5542% | -8.2836% | -2.963% | 19.8276% | 33.7838% | 208.9431% | 22.2222% | -2.8846% | 108% | 210.5263% | -1.626% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NGVT
2026-08-05 14:10:46
Ingevity Corporation has released its 2025 Sustainability Report, "A Decade of Performance, a Future of Possibility," highlighting how its advanced materials and technologies contribute to environmental goals such as reduced emissions, extended infrastructure life, cleaner water, and the use of renewable raw materials. The report details the company's commitment to creating value for customers and stakeholders by purifying, protecting, and enhancing the world. It also outlines efforts to support a global vision for a more sustainable world, adhering to Global Reporting Initiative (GRI) and Sustainability Accounting Standards Board (SASB) standards.
2026-08-03 20:11:21
This article reports on an Ingevity Corp (NGVT) SEC Form 144 filing from August 3, 2026. The filing indicates a proposed sale of 2,709 shares of common stock by an unnamed person, acquired through restricted stock on February 18, 2021, with an aggregate market value of $199,703.80. The sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE.
2026-08-03 03:40:31
Ingevity (NGVT) recently reported Q2 2026 results, showing improved profitability compared to the previous year, despite lower sales, and announced the completion of a multi-year share repurchase program. While the company's share price has seen significant gains year-to-date and over the last year, its valuation, with a P/E ratio of 100.9x, is considerably higher than industry averages, presenting potential valuation risk if future growth falls short of ambitious analyst expectations. Analysts project a fair value of $89 per share, suggesting the stock is undervalued, but this hinges on significant profit margin increases and specific assumptions about future cash flows.
2026-08-01 02:41:07
Ingevity Corp (NGVT) shares surged 4.2% to $73.11, but GuruFocus's GF Value™ indicates the stock is significantly overvalued by 59.0% compared to its estimated intrinsic value of $45.99. Despite a GF Score™ of 62/100, highlighting strong profitability and momentum, the company faces challenges in financial strength and growth. Investors are advised to exercise caution due to the overvaluation and mixed signals from institutional investors and a lack of insider activity.
2026-07-31 23:11:53
Ingevity Corp (NGVT) shares surged 4.2% to $73.11, despite a GuruFocus (GF) Score of 62/100 indicating above-average performance but also weaknesses. The stock is considered significantly overvalued with its current price being 59.0% above the GF Value estimate, and its P/E ratio of 49.7x is much higher than its historical median. Mixed activity from institutional investors and an absence of insider trading suggest caution is warranted.
2026-07-30 20:09:19
Ingevity Corp reported its second-quarter 2026 results, showing revenue of $314.1M, net income of $35.3M, and diluted EPS of $1. This represents a significant improvement compared to the prior-year quarter's net loss and diluted loss per share. The company's net sales declined by about 5% year-over-year, primarily due to divestitures, although Performance Materials and APT segments showed growth and improved pricing.
